| Literature DB >> 31950298 |
A Faragli1,2,3, R Tanacli4, C Kolp1, T Lapinskas4,5, C Stehning6, B Schnackenburg6, F P Lo Muzio7,8, S Perna9, B Pieske1,2,3,4, E Nagel10, H Post1,2,3,11, S Kelle1,2,3, A Alogna12,13,14.
Abstract
Cardiovascular magnetic resonance feature tracking (CMR-FT) is a novel technique for non-invasive assessment of myocardial motion and deformation. Although CMR-FT is standardized in humans, literature on comparative analysis from animal models is scarce. In this study, we measured the reproducibility of global strain under various inotropic states and the sample size needed to test its relative changes in pigs. Ten anesthetized healthy Landrace pigs were investigated. After baseline (BL), two further steps were performed: (I) dobutamine-induced hyper-contractility (Dob) and (II) verapamil-induced hypocontractility (Ver). Global longitudinal (GLS), circumferential (GCS) and radial strain (GRS) were assessed. This study shows a good to excellent inter- and intra-observer reproducibility of CMR-FT in pigs under various inotropic states. The highest inter-observer reproducibility was observed for GLS at both BL (ICC 0.88) and Ver (ICC 0.79). According to the sample size calculation for GLS, a small number of animals could be used for future trials.Entities:
Keywords: Cardiovascular magnetic resonance; Feature tracking; Left ventricular strain; Porcine model; Reproducibility; Sample size
Mesh:
Substances:
Year: 2020 PMID: 31950298 PMCID: PMC7125242 DOI: 10.1007/s10554-020-01767-y
Source DB: PubMed Journal: Int J Cardiovasc Imaging ISSN: 1569-5794 Impact factor: 2.357
Fig. 1The experimental setting. The animals were acutely instrumented closed chest in the operating room (a, b) and then transported to the MRI facility where anesthesia and monitoring was maintained during the whole experimental protocol (c, d)
Fig. 2Bland–Altman plots for inter-observer reproducibility of global strain values. Bland–Altman plots showing inter-observer reproducibility for GLS (top row, panels a–c), GCS (middle row, panels d–f) and GRS analysis (bottom row, panels g–i) during BL, Dob and Ver steps respectively. BL baseline, Dob Dobutamine, Ver Verapamil, GLS global longitudinal strain, GCS global circumferential strain, GRS global radial strain
Fig. 3Bland–Altman plots for intra-observer reproducibility of global strain values. Bland–Altman plots showing intra-observer reproducibility for GLS (top row, panels a–c), GCS (middle row, panels d–f) and GRS analysis (bottom row, panels g–i) during BL, Dob and Ver steps respectively. BL baseline, Dob Dobutamine, Ver Verapamil, GLS global longitudinal strain, GCS global circumferential strain, GRS global radial strain
Fig. 4Graphical representation of the sample size calculation for global strain values. Representation of the sample size calculation for GLS (blue), GCS (red) and GRS (green) baseline measurements to detect the desired % relative change of strain with 80% power and α error of 0.05. Dashed lines represent the relative change of strain at 5%, 10% and 15% respectively. GLS global longitudinal strain, GCS global circumferential strain, GRS global radial strain
Volumetric and functional characteristics of study subjects
| Parameter | Value | |
|---|---|---|
| Study population | 10 | |
| LV EDV (ml) | BL | 101 ± 24 |
| Dob | 83 ± 21* | |
| Ver | 108 ± 25† | |
| LV ESV (ml) | BL | 41 ± 10 |
| Dob | 19 ± 7* | |
| Ver | 66 ± 18*† | |
| LV SV (ml) | BL | 60 ± 19 |
| Dob | 64 ± 18 | |
| Ver | 42 ± 12*† | |
| LV EF (%) | BL | 59 ± 8 |
| Dob | 77 ± 7* | |
| Ver | 39 ± 9*† | |
| Cardiac output (l/min) | BL | 6 ± 1 |
| Dob | 9 ± 2* | |
| Ver | 4 ± 1*† | |
| Heart rate (bpm) | BL | 106 ± 15 |
| Dob | 146 ± 12* | |
| Ver | 98 ± 19† | |
| LV Mass (g) | 81 ± 20 |
Results are reported as mean ± standard deviation
BL baseline, Dob Dobutamine, EDV end-diastolic volume, EF ejection fraction, ESV end-systolic volume, LV left ventricle/ventricular
SV stroke volume, Ver Verapamil
*p-value < 0.05 versus BL
†p-value < 0.05 versus Dob
Comparison of CMR-FT derived average of global strain parameters obtained by observers in ten pigs during BL, Dob and Ver steps
| Measurements obtained by two observers (inter-observer level) | ||
|---|---|---|
| First observer | Second observer | |
| BL (%) | ||
| GLS | − 26.1 ± 5 | − 25.1 ± 4 |
| GCS | − 32.7 ± 8 | − 30.4 ± 6 |
| GRS | 73.3 ± 9 | 51.5 ± 17 |
| Dob (%) | ||
| GLS | − 45.1 ± 11* | − 40.6 ± 7* |
| GCS | − 55.1 ± 12 | − 54.7 ± 10* |
| GRS | 103.0 ± 20 | 101.8 ± 14* |
| Ver (%) | ||
| GLS | − 20.8 ± 6† | − 17.3 ± 5*† |
| GCS | − 18.6 ± 4† | − 21.0 ± 6*† |
| GRS | 53.9 ± 10† | 29.1 ± 9*† |
All the operators took the measurements twice and the average values were taken
BL baseline, Dob Dobutamine, GCS global circumferential strain, GLS global longitudinal strain, GRS global radial strain, Ver Verapamil
*p-value < 0.05 versus BL
†p value < 0.05 versus Dob
Inter-observer and intra-observer reproducibility for GLS, GCS and GRS
| Parameter | Steps | Mean difference ± SD | Limits of agreement | ICC (95% CI) | |
|---|---|---|---|---|---|
| Inter-observer variability | GLS | BL | − 1.0 ± 3.0 | − 6.9 to 4.8 | 0.88 (0.57–0.97) |
| Dob | − 4.5 ± 10.0 | − 24.1 to 15.1 | 0.60 (− 0.35 to 0.89) | ||
| Ver | 3.5 ± 4.2 | − 4.7 to 11.7 | 0.79 (0.10–0.95) | ||
| GCS | BL | − 2.2 ± 7.6 | − 17.2 to 12.6 | 0.66 (− 0.21 to 0.92) | |
| Dob | − 0.4 ± 11.5 | − 23.0 to 22.2 | 0.51 (− 0.23 to 0.87) | ||
| Ver | 2.4 ± 3.4 | − 4.3 to 9.2 | 0.61 (− 0.40 to 0.90) | ||
| GRS | BL | 21.7 ± 11.6 | − 0.9 to 44.5 | 0.80 (0.21–0.95) | |
| Dob | 1.2 ± 29.6 | − 56.9 to 59.3 | − 1.60 (− 9.47 to 0.35) | ||
| Ver | 24.7 ± 12.6 | 0.1 to 49.4 | 0.24 (− 2.03 to 0.81) | ||
| Intra-observer variability | GLS | BL | 2.8 ± 2.9 | − 2.8 to 8.5 | 0.81 (0.41–0.95) |
| Dob | − 0.4 ± 7.3 | − 14.8 to 14.0 | 0.87 (0.45–0.96) | ||
| Ver | 4.3 ± 4.3 | − 4.1 to 12.7 | 0.75 (0.01–0.94) | ||
| GCS | BL | 1.7 ± 1.5 | − 1.3 to 4.7 | 0.98 (0.77–0.99) | |
| Dob | 1.8 ± 3.4 | − 4.8 to 8.4 | 0.97 (0.89–0.99) | ||
| Ver | 1.6 ± 1.4 | − 1.1 to 4.4 | 0.95 (0.36–0.99) | ||
| GRS | BL | − 1.5 ± 12.7 | − 26.4 to 23.3 | 0.79 (0.15–0.94) | |
| Dob | − 15.1 ± 31.1 | − 76.0 to 45.8 | 0.62 (− 0.50 to 0.90) | ||
| Ver | − 23.6 ± 15.7 | − 54.4 to 7.2 | 0.14 (− 2.43 to 0.78) |
Results are reported as mean ± standard deviation
BL baseline, CI confidence interval, Dob Dobutamine, GCS global circumferential strain, GLS global longitudinal strain, GRS global radial strain, ICC intra-class correlation coefficient, Ver Verapamil
Sample size calculation for GLS, GCS and GRS (baseline measurements) to detect the desired % relative change with 80% power and α error of 0.05
| Mean difference ± SD pooled | Sample size (n) | |||
|---|---|---|---|---|
| 5% | 10% | 15% | ||
| GLS | − 1.1 ± 4.9 | 20 | 5 | 2 |
| GCS | − 2.3 ± 7.4 | 45 | 11 | 5 |
| GRS | 21.7 ± 17.9 | NA | 68 | 30 |
The mean difference is calculated from the inter-observer mean difference analysis. The pooled SD has been obtained by applying Cohen formula: SDpooled = √ (SD12 + SD22)−1
GCS global circumferential strain, GLS global longitudinal strain, GRS global radial strain, SD standard deviation